The transient receptor potential melastatin 2: a new therapeutical target for Parkinson's disease?
Ana Flávia F.Ferreira
Luiz Roberto G.Britto
Keywords：1-methyl-4-phenyl-1236-tetrahydropyridine (MPTP)1-methyl-4-phenylpyridinium(MPP+)6-hydroxydopamineAG490clotrimazoleflufenamic acidN-(p-amylcinnamoyl) anthranilic acidarkinson’s diseasepoly-ADPR polymerase type 1 (PARP1)rotenoneparaquattransi
Publication Date：2023-08-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 1652-1656 )